mooseman109
Active Member
Had an MI in April, been on crestor since, not side effects for me. Total chocolate is 100 give or take and ldl is mid 30’s. Was right at upper limit before
Its not nonsense. Its the truth. I have a genetic mutation of the 13 gene, giving me abolition of ldl receptor activity on the y chromosome. (HeFh)
The consequence of this is massively raised LDL-c.
The hypothesis that high LDL is causative towards heart disease was utterly ruined once many individuals with the same familial hypercholesterolemia gene mutation as myself, which causes very high levels of LDL-c were found to have no incidence of CVD, nor evidence of atherosclerosis of any kind under examination.
In short, some people with hypercholesterolemia have heart disease, some dont. Proving that LDL-c isnt, and never was the cause of CVD.
The ‘theory’ or hypothesis that high ldl-c is a marker for CVD is dead in the water. All current evidence points towards clotting, thrombus, endothelial inflammation and intestinal issues.
The majority of cvd patients have ldl-c well within the ‘recommended’ parameters. The same for those dying from myocardial infarctions. (LDL-c within the guideline range)
Statins are actually dangerous from the pov of cvd as they ‘encourage’ the calcium levels within arterial plaque to rise. The idea being that this promotes stability within the lesion.
If anything, they are causative towards angina and other coronary calcification issues such as aortic stenosis and heart valve issues.
The use of statin therapy for cvd is one of the biggest lies in the history of medicine.
Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death
Nov 24, 2019
Over 50 million secondary prevention patients worldwide with atherosclerotic cardiovascular disease (ASCVD) or familial hypercholesterolemia (FH) on current standard of care do not achieve LDL cholesterol (LDL-C) goal and remain at increased risk of cardiovascular events1
Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death | Novartis
“If the outcomes trials validate what most of us think it will or hope it will, [inclisiran] will be more broadly used than just a niche, I think, because there is so much of a burden of atherosclerosis that remains that we’re not addressing that this could be a powerful tool,” according to Watson.
“If this drug is approved, it will be nice to have a second option to lower LDL in the PCSK9 pathway,” Wright said. “Then the question becomes: is it more convenient to take a drug twice a year versus 26 times a year and what's the value to patients?” He acknowledged not knowing how inclisiran will be priced but said “those are issues to be considered.”
“Inclisiran is the first cholesterol-lowering agent in the siRNA class that opens up a whole host of new and exciting possibilities, and definitely increasing the number and types of effective therapeutic options that our patients have available to them is good medicine,” Watson concluded.
I use a pcsk9 inhibitor Vince. 1 year in so far. They have a terrific effect on the endothelial function, and so far, no major side effects.Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death
Nov 24, 2019
Over 50 million secondary prevention patients worldwide with atherosclerotic cardiovascular disease (ASCVD) or familial hypercholesterolemia (FH) on current standard of care do not achieve LDL cholesterol (LDL-C) goal and remain at increased risk of cardiovascular events1
Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death | Novartis
Im on one. (PCSK9 INHIBITOR) 2/monthThese drugs are going to change the world (once they're cheap enough for normal people to use!) Inclisiran is a PCSK9 inhibitor (NOT a statin!), but works differently than existing PCSK9 inhibitors and only needs to be injected twice a year:
PCSK9 inhibitors are incredible. They aren't statins - they don't inhibit cholesterol synthesis inside of cells. They create more LDL receptors, increasing the clearance of LDL.
Because of this, LDL can be driven very, very low without the same side effects you see with statins. With a high dose of statins, side effects may appear because you increasingly inhibit cholesterol synthesis in cells.
Im on one. (PCSK9 INHIBITOR) 2/month
The effect on intima inflammation appears to be profound. Which is the no.1 reason i use them TBH.
This is complete and utter nonsense. I’ve been researching CVD for 10 years (since my father got sick).
This forum, like many places on the Internet, is extremely biased against statins and in general the idea of fixing your poor blood lipids. Please be careful taking advice here.
My LDL particle number is very high. The overall cholesterol is 199 but LDL is 123. That said, the particle number is extremely high.
1)Can diet alone lower particle number?
2) i also read about taking low dose cestor ( 5 mgs) every other day to reduce potential side effects. I even see studies where people take it once per week.
In short, some people with hypercholesterolemia have heart disease, some dont. Proving that LDL-c isnt, and never was the cause of CVD.
Correlation isn’t causation, and that’s my point.In short, lipid levels still correlate to CVD. The moving target is which lipids, trg/LDL ratios, particle sizes and ratios, various confounders, etc. There's obviously other risk factors unrelated to lipid levels that dictate CVD or not, some of which we have control over, some of which we don't. For sure, the old models are of minimal value, but saying hypercholesterolemia is unrelated to CVD is simple false. It's a generalization no better than saying everone with hypercholesterolemia will get CVD.
If you are on statins, have gingivitis and reduced heart ejection fraction, take this supplement. The speaker recommends 150 mg three times per day. I take it for protection.
Peter Langsjoen, MD discusses why we should take Coenzyme Q10
Do you take 150mg three times a day? I’ve been taking 100mg twice a day. It’s fairly expensive in supplement terms and I worry about using too much?
Correlation isn’t causation, and that’s my point.
If only one person with heFH doesn’t have CVD, then this is definitive proof that LDL isn’t the cause, and merely has a correlation to CVD.
Focus needs to be on causation factors, not shitty correlations.
There are elephants in the room with ‘causation’ tattooed onto their foreheads, which outway correlations by 1000’s of percentages in terms of risk factors for CVD, yet much attention is still focused on LDL, when energy and effort would have been best spent elsewhere.
It’s cost the lives of millions.
Don't worry about taking too much. I'm presently taking 400 mg twice a day. I've had my levels checked and they are way over range. I am told by my doctor, high levels will not harm me. I also think it's not necessary to have levels as high as mine.Do you take 150mg three times a day? I’ve been taking 100mg twice a day. It’s fairly expensive in supplement terms and I worry about using too much?
Can people use it for long term? What about fenofibrate?My wife uses crestor. The generic brand, very inexpensive. She has no issues from using it. Her LDL cholesterol is now very good. It also helped her particle count. Her bad particle count did go lower and her good protocol number increased.
Does TRT decreasd your LDL cholestrol?I was prescribed Lipitor in 2008. It initially gave me severe muscle cramping in my lower back. I discovered that supplementing with COQ10 helped a lot with the cramping. Recently with TRT and thyroid meds, my cholesterol levels dropped back into the normal range, and I've been without the Lipitor for about 6 months.